Abstract
Background
Despite significant advances in imaging and genetics, as well as surgical and anesthetic innovations, morbidity in pheochromocytoma surgery remains significant. The aim of this study was to identify the predictive factors of global and cardiovascular morbidity following unilateral laparoscopic adrenalectomy for pheochromocytoma.
Methods
We conducted a retrospective study from a unicentric cohort. All patients who underwent non-converted laparoscopic unilateral adrenalectomy for pheochromocytoma between 2000 and 2017 were included. Our patients did not systematically benefit from preoperative pharmacological preparation. It is to be noted that they never received alpha-blockers. Preoperative, intraoperative, and postoperative data during follow-ups were collected. Univariate and multivariate analyses by logistic regression were performed.
Results
A total of 134 patients were included. Fifty-three percent of patients did not receive preoperative pharmacological preparation (PPP) and 33% neither preoperative antihypertensives nor PPP before surgery. There was no postoperative mortality. The global morbidity was 13.4%, while cardiovascular morbidity was 4.5%. The main factors associated with global morbidity were preoperative diuretics, a medical history of stroke, and the need for pressor amines postoperatively. The main factor associated with cardiovascular morbidity was the need for pressor amines postoperatively. Predictive factors of postoperative need for pressor amines for hypotension were the tumor size, preoperative beta-blockers, and/or diuretics.
Conclusion
In this large cohort of patients, our data revealed no mortality and low global and cardiovascular morbidity rates, showing that pheochromocytoma surgery without systematic PPP and even without preoperative antihypertensives is feasible and safe for selected patients. Our data also highlight the need for a good preoperative evaluation of the patient and the tumor, in order to optimize treatments and to help the detection of high-risk patients. This also allows us to better prevent and anticipate their possible complications.
Similar content being viewed by others
References
Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL (2003) Pheochromocytoma: the expanding genetic differential diagnosis. J Natl Cancer Inst 95:1196–1204. https://doi.org/10.1093/jnci/djg024
Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, Chamontin B, Delemer B, Giraud S, Murat A, Niccoli-Sire P, Richard S, Rohmer V, Sadoul J-L, Strompf L, Schlumberger M, Bertagna X, Plouin P-F, Jeunemaitre X, Gimenez-Roqueplo A-P (2005) Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 23:8812–8818. https://doi.org/10.1200/JCO.2005.03.1484
Shen WT, Grogan R, Vriens M, Clark OH (1960) Duh Q-Y (2010) One hundred two patients with pheochromocytoma treated at a single institution since the introduction of laparoscopic adrenalectomy. Arch Surg Chic Ill 145:893–897. https://doi.org/10.1001/archsurg.2010.159
Thompson GB, Grant CS, van Heerden JA, Schlinkert RT, Young WF, Farley DR, Ilstrup DM (1997) Laparoscopic versus open posterior adrenalectomy: a case–control study of 100 patients. Surgery 122:1132–1136
Kercher KW, Novitsky YW, Park A, Matthews BD, Litwin DEM, Heniford BT (2005) Laparoscopic curative resection of pheochromocytomas. Ann Surg 241:919–926. https://doi.org/10.1097/01.sla.0000164175.26785.06. (discussion 926-928)
Frunzac R (2016) Pheochromocytoma. In: Duh QY, Clark OH (eds) Textbook of endocrine surgery. Jaypee Brothers Medical Publishers, Philadelphia, pp 1047–1067
Brunaud L, Nguyen-Thi P-L, Mirallie E, Raffaelli M, Vriens M, Theveniaud P-E, Boutami M, Finnerty BM, Vorselaars WMCM, Rinkes IB, Bellantone R, Lombardi C, Fahey T, Zarnegar R, Bresler L (2016) Predictive factors for postoperative morbidity after laparoscopic adrenalectomy for pheochromocytoma: a multicenter retrospective analysis in 225 patients. Surg Endosc 30:1051–1059. https://doi.org/10.1007/s00464-015-4294-7
Bruynzeel H, Feelders RA, Groenland THN, van den Meiracker AH, van Eijck CHJ, Lange JF, de Herder WW, Kazemier G (2010) Risk factors for hemodynamic instability during surgery for pheochromocytoma. J Clin Endocrinol Metab 95:678–685. https://doi.org/10.1210/jc.2009-1051
Kinney MA, Warner ME, vanHeerden JA, Horlocker TT, Young WF, Schroeder DR, Maxson PM, Warner MA (2000) Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. Anesth Analg 91:1118–1123
Lentschener C, Gaujoux S, Tesniere A, Dousset B (2011) Point of controversy: perioperative care of patients undergoing pheochromocytoma removal-time for a reappraisal? Eur J Endocrinol 165:365–373. https://doi.org/10.1530/EJE-11-0162
Wu S, Chen W, Shen L, Xu L, Zhu A, Huang Y (2017) Risk factors for prolonged hypotension in patients with pheochromocytoma undergoing laparoscopic adrenalectomy: a single-center retrospective study. Sci Rep 7:5897. https://doi.org/10.1038/s41598-017-06267-z
Plouin PF, Duclos JM, Soppelsa F, Boublil G, Chatellier G (2001) Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. J Clin Endocrinol Metab 86:1480–1486. https://doi.org/10.1210/jcem.86.4.7392
Lafont M, Fagour C, Haissaguerre M, Darancette G, Wagner T, Corcuff JB, Tabarin A (2015) Per-operative hemodynamic instability in normotensive patients with incidentally discovered pheochromocytomas. J Clin Endocrinol Metab 100:417–421. https://doi.org/10.1210/jc.2014-2998
Hull CJ (1986) Phaeochromocytoma. Diagnosis, preoperative preparation and anaesthetic management. Br J Anaesth 58:1453–1468. https://doi.org/10.1093/bja/58.12.1453
Apgar V, Papper EM (1951) Pheochromocytoma. Anesthetic management during surgical treatment. AMA Arch Surg 62:634–648
Desmonts JM, Marty J (1984) Anaesthetic management of patients with phaeochromocytoma. Br J Anaesth 56:781–789. https://doi.org/10.1093/bja/56.7.781
Boutros AR, Bravo EL, Zanettin G, Straffon RA (1990) Perioperative management of 63 patients with pheochromocytoma. Cleve Clin J Med 57:613–617
Lenders JWM, Duh Q-Y, Eisenhofer G, Gimenez-Roqueplo A-P, Grebe SKG, Murad MH, Naruse M, Pacak K, Young WF, Endocrine Society (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:1915–1942. https://doi.org/10.1210/jc.2014-1498
Brunaud L, Boutami M, Nguyen-Thi P-L, Finnerty B, Germain A, Weryha G, Fahey TJ, Mirallie E, Bresler L, Zarnegar R (2014) Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma. Surgery 156:1410–1417. https://doi.org/10.1016/j.surg.2014.08.022. (discussion1417-1418)
Lebuffe G, Dosseh ED, Tek G, Tytgat H, Moreno S, Tavernier B, Vallet B, Proye C (2005) The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas. Anaesthesia 60:439–444. https://doi.org/10.1111/j.1365-2044.2005.04156.x
Isaacs M, Lee P (2017) Preoperative alpha-blockade in phaeochromocytoma and paraganglioma: is it always necessary? Clin Endocrinol (Oxf) 86:309–314. https://doi.org/10.1111/cen.13284
Duh QY (2001) Evolving surgical management for patients with pheochromocytoma. J Clin Endocrinol Metab 86:1477–1479. https://doi.org/10.1210/jcem.86.4.7519
Gaujoux S, Bonnet S, Lentschener C, Thillois J-M, Duboc D, Bertherat J, Samama CM, Dousset B (2016) Preoperative risk factors of hemodynamic instability during laparoscopic adrenalectomy for pheochromocytoma. Surg Endosc 30:2984–2993. https://doi.org/10.1007/s00464-015-4587-x
Bai S, Yao Z, Zhu X, Li Z, Jiang Y, Wang R, Wu B (2018) Risk factors for postoperative severe morbidity after pheochromocytoma surgery: a single center retrospective analysis of 262 patients. Int J Surg 60:188–193. https://doi.org/10.1016/j.ijsu.2018.11.019
le Schweitzer M, Nguyen-Thi P-L, Mirallie E, Vriens M, Raffaelli M, Klein M, Zarnegar R, Brunaud L (2019) Conversion during laparoscopic adrenalectomy for pheochromocytoma: a cohort study in 244 patients. J Surg Res 243:309–315. https://doi.org/10.1016/j.jss.2019.05.042
Kiernan CM, Du L, Chen X, Broome JT, Shi C, Peters MF, Solorzano CC (2014) Predictors of hemodynamic instability during surgery for pheochromocytoma. Ann Surg Oncol 21:3865–3871. https://doi.org/10.1245/s10434-014-3847-7
Weingarten TN, Cata JP, O’Hara JF, Prybilla DJ, Pike TL, Thompson GB, Grant CS, Warner DO, Bravo E, Sprung J (2010) Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. Urology 76:508.e6–11. https://doi.org/10.1016/j.urology.2010.03.032
Scholten A, Vriens MR, Cromheecke GJE, Borel Rinkes IHM, Valk GD (2011) Hemodynamic instability during resection of pheochromocytoma in MEN versus non-MEN patients. Eur J Endocrinol 165:91–96. https://doi.org/10.1530/EJE-11-0148
Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae
Namekawa T, Utsumi T, Kawamura K, Kamiya N, Imamoto T, Takiguchi T, Hashimoto N, Tanaka T, Naya Y, Suzuki H, Ichikawa T (2016) Clinical predictors of prolonged postresection hypotension after laparoscopic adrenalectomy for pheochromocytoma. Surgery 159:763–770. https://doi.org/10.1016/j.surg.2015.09.016
Randle RW, Balentine CJ, Pitt SC, Schneider DF, Sippel RS (2017) Selective versus non-selective α-blockade prior to laparoscopic adrenalectomy for pheochromocytoma. Ann Surg Oncol 24:244–250. https://doi.org/10.1245/s10434-016-5514-7
Groeben H, Nottebaum BJ, Alesina PF, Traut A, Neumann HP, Walz MK (2017) Perioperative α-receptor blockade in phaeochromocytoma surgery: an observational case series. Br J Anaesth 118:182–189. https://doi.org/10.1093/bja/aew392
van der Zee PA, de Boer A (2014) Pheochromocytoma: a review on preoperative treatment with phenoxybenzamine or doxazosin. Neth J Med 72:190–201
Livingstone M, Duttchen K, Thompson J, Sunderani Z, Hawboldt G, Sarah Rose M, Pasieka J (2015) Hemodynamic stability during pheochromocytoma resection: lessons learned over the last two decades. Ann Surg Oncol 22:4175–4180. https://doi.org/10.1245/s10434-015-4519-y
Acknowledgements
Thanks to Charlotte Kelway and Romain Isenbart for their contribution in this paper.
Funding
The authors have received no financial support for publication of this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Cyrille Buisset, Carole Ghérin, Pierre-Julien Cungi, Mickael Gardette, Nunzia-Cinzia Paladino, Thomas Cuny, David Taïeb, Fréderic Castinetti, Fréderic Sebag have no conflicts of interest or financial ties to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Buisset, C., Guerin, C., Cungi, PJ. et al. Pheochromocytoma surgery without systematic preoperative pharmacological preparation: insights from a referral tertiary center experience. Surg Endosc 35, 728–735 (2021). https://doi.org/10.1007/s00464-020-07439-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-020-07439-1